$SWISF ACCESSWIRE / June 1, 2022 / Sekur Private Data Ltd.

New Post Public Reply Private Reply Replies (0) Message Board
budfoxfun
161
$SWISF ACCESSWIRE / June 1, 2022 / Sekur Private Data Ltd. (OTCQX:SWISF) (CSE:SKUR) (FRA:GDT0) ("Sekur" or the "Company", the leader in Swiss hosted secure communications and secure data management, is pleased announce that, as part of its US mass marketing strategy to bring awareness to Sekur Private Data's Sekur solution, it has signed a contract with The Epoch Times to become the exclusive sponsor of Roman Balmakov's episodes on EpochTV for all of his shows every Wednesday and every Friday for the remainder of 2022 and all of 2023. The total amount of sponsored episodes amounts to 158 episodes starting June 29th 2022 and ending December 31 2023. These episodes are in addition to the YouTube episodes already being sponsored by the Company at a rate of 12 episodes a month on average for Roman Balmakov.

The sponsored ads will describe Sekur's attributes as the leading Swiss hosted Privacy and Security communications application, such as encrypted email and secure messaging, without any data mining, including Sekur's unique proprietary feature called Chats-by-invites, letting a Sekur user message a non-Sekur user, without the recipient having to download Sekur, and its proprietary SekurSend feature letting a user send a private email to anyone in the globe without the recipient's ISP being able to read the content or do any data mining on it. EpochTV is only viewable by The Epoch Times' 1.5 million paying members and offers exclusive programs and episodes which are different than the episodes aired on YouTube.

The sponsored program will be Facts Matter with Roman Balmakov. Additionally, followers will benefit from a 25% discount Promo code for the first 5 years of subscription to Sekur at the time of signup. The average Facts Matter episode on EpochTV gets well over 150,000 views, with some reaching 250,000 views.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Huawei Introduces Innovative Wearables for Enhanced Connectivity

Updated Category News Views 293

Huawei Unveils Next-Generation Wearables and Tablets At a much-anticipated event, Huawei Consumer Business Group (CBG) revealed a thrilling array of new products. This launch showcased a strong emphasis on trendy wearables and sophisticated tablets, highlighting the brand's dedication to innovation and a user-friendly design. Chic Wearables for Style and Utility Among the...

Continue Reading
Investigating Barnes & Noble Education: Shareholder Rights Explained

Updated Category News Views 155

Understanding the Investigation of Barnes & Noble Education In a proactive move for investors, the law firm Bragar Eagel & Squire, P.C. is currently investigating Barnes & Noble Education, Inc. (BNED). This investigation aims to determine whether the company potentially breached federal securities laws or engaged in unlawful business practices that could lead to...

Continue Reading
Bailey Kennedy Achieves Landmark Legal Win for Talisman Group

Updated Category News Views 171

Bailey Kennedy Achieves Legal Victory for Talisman Group Judge Rules LNW Violated Talisman's Distribution Agreement by Marketing Competing Game In a significant legal development, Bailey Kennedy, LLP has successfully represented The Talisman Group, LLC, the innovative minds behind EZ Baccarat. The firm has recently triumphed in a legal dispute against LNW Gaming, Inc.,...

Continue Reading
Join the Class Action Lawsuit Against Ardelyx, Inc. Now

Updated Category News Views 49

Join the Class Action Lawsuit Against Ardelyx, Inc. Attention Ardelyx, Inc. investors! There's an important class action lawsuit underway, and this is your opportunity to get involved. Bronstein, Gewirtz & Grossman, LLC, a respected law firm known for its dedication to investor advocacy, has announced a class action case involving Ardelyx, Inc. (NASDAQ: ARDX) and certain...

Continue Reading
Aileron Therapeutics Unveils Q3 2024 Financial Performance

Updated Category News Views 97

Aileron Therapeutics Reports Impressive Q3 2024 Financial Results Aileron Therapeutics, Inc. (NASDAQ: ALRN), a biopharmaceutical company committed to developing innovative medicines for orphan pulmonary diseases, has recently showcased significant progress with their third-quarter financial results. This quarter has been marked by promising advancements in clinical trials...

Continue Reading